Skip to main content
. 2023 Nov 4;339:199258. doi: 10.1016/j.virusres.2023.199258

Fig. 9.

Fig 9

Broad-spectrum antiviral activity of TET. (A) Cell viability of cells (Vero, MDBK and IPEC-J2) treated with TET at the indicated concentration. (B) CC50 of TET on Vero, MDBK and IPEC-J2 cell. Western Blot assay showed that the protein level of (C-D) LSDV 117 and (E-F) PEDV N decreased significantly in a dose-dependent manner after TET treatment.